- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | -0.18 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2022 (9) | 0.07 | -61.11 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2021 (8) | 0.18 | 500.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2020 (7) | 0.03 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2019 (6) | -0.57 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2018 (5) | -0.45 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2017 (4) | -0.81 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2016 (3) | -1.52 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | -0.21 | -163.64 | -200.0 | 0.05 | -72.22 | 122.73 | 0.29 | -42.0 | 281.25 |
24Q2 (19) | 0.33 | 94.12 | 0 | 0.18 | 460.0 | 300.0 | 0.50 | 194.12 | 655.56 |
24Q1 (18) | 0.17 | 950.0 | 270.0 | -0.05 | 28.57 | -400.0 | 0.17 | 194.44 | 270.0 |
23Q4 (17) | -0.02 | 71.43 | 0.0 | -0.07 | 68.18 | -333.33 | -0.18 | -12.5 | -357.14 |
23Q3 (16) | -0.07 | 0 | -187.5 | -0.22 | -144.44 | -340.0 | -0.16 | -77.78 | -277.78 |
23Q2 (15) | 0.00 | 100.0 | -100.0 | -0.09 | -800.0 | -800.0 | -0.09 | 10.0 | -550.0 |
23Q1 (14) | -0.10 | -400.0 | -100.0 | -0.01 | -133.33 | 83.33 | -0.10 | -242.86 | -100.0 |
22Q4 (13) | -0.02 | -125.0 | 75.0 | 0.03 | 160.0 | 175.0 | 0.07 | -22.22 | -61.11 |
22Q3 (12) | 0.08 | 33.33 | -55.56 | -0.05 | -400.0 | -127.78 | 0.09 | 350.0 | -66.67 |
22Q2 (11) | 0.06 | 220.0 | -25.0 | -0.01 | 83.33 | -108.33 | 0.02 | 140.0 | -80.0 |
22Q1 (10) | -0.05 | 37.5 | -600.0 | -0.06 | -50.0 | -220.0 | -0.05 | -127.78 | -600.0 |
21Q4 (9) | -0.08 | -144.44 | -366.67 | -0.04 | -122.22 | -233.33 | 0.18 | -33.33 | 500.0 |
21Q3 (8) | 0.18 | 125.0 | 263.64 | 0.18 | 50.0 | 300.0 | 0.27 | 170.0 | 0 |
21Q2 (7) | 0.08 | 700.0 | 300.0 | 0.12 | 140.0 | 400.0 | 0.10 | 900.0 | -9.09 |
21Q1 (6) | 0.01 | -66.67 | -93.33 | 0.05 | 66.67 | 127.78 | 0.01 | -66.67 | -93.33 |
20Q4 (5) | 0.03 | 127.27 | 107.69 | 0.03 | 133.33 | 160.0 | 0.03 | 0 | 105.26 |
20Q3 (4) | -0.11 | -175.0 | 0.0 | -0.09 | -125.0 | 0.0 | 0.00 | -100.0 | 0.0 |
20Q2 (3) | -0.04 | -126.67 | 0.0 | -0.04 | 77.78 | 0.0 | 0.11 | -26.67 | 0.0 |
20Q1 (2) | 0.15 | 138.46 | 0.0 | -0.18 | -260.0 | 0.0 | 0.15 | 126.32 | 0.0 |
19Q4 (1) | -0.39 | 0.0 | 0.0 | -0.05 | 0.0 | 0.0 | -0.57 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 0.87 | -15.11 | 16.98 | 11.08 | 24.23 | 2.94 | N/A | - | ||
2024/10 | 1.03 | -1.26 | 32.87 | 10.23 | 25.33 | 2.87 | N/A | - | ||
2024/9 | 1.04 | 29.81 | 12.03 | 9.2 | 24.45 | 2.81 | 2.65 | - | ||
2024/8 | 0.8 | -17.05 | 7.25 | 8.13 | 24.65 | 2.86 | 2.6 | - | ||
2024/7 | 0.97 | -11.38 | 48.35 | 7.32 | 27.93 | 3.08 | 2.42 | - | ||
2024/6 | 1.09 | 7.1 | 19.14 | 6.35 | 25.31 | 3.51 | 1.8 | - | ||
2024/5 | 1.02 | -27.05 | 16.08 | 5.25 | 26.66 | 3.15 | 2.0 | - | ||
2024/4 | 1.4 | 90.1 | 93.19 | 4.24 | 29.68 | 3.03 | 2.08 | 全球市場對本公司產品需求強勁 | ||
2024/3 | 0.73 | -18.43 | -12.13 | 2.85 | 11.78 | 2.82 | 2.18 | - | ||
2024/2 | 0.9 | -24.1 | 5.29 | 2.09 | 22.4 | 2.96 | 2.07 | - | ||
2024/1 | 1.19 | 35.9 | 39.02 | 1.19 | 39.02 | 2.81 | 2.19 | - | ||
2023/12 | 0.87 | 17.07 | -13.34 | 9.8 | -10.08 | 2.39 | 2.47 | - | ||
2023/11 | 0.75 | -3.58 | -21.89 | 8.92 | -9.78 | 2.45 | 2.41 | - | ||
2023/10 | 0.77 | -16.75 | -16.77 | 8.16 | -8.51 | 2.45 | 2.41 | - | ||
2023/9 | 0.93 | 24.27 | -0.31 | 7.4 | -7.42 | 2.33 | 2.54 | - | ||
2023/8 | 0.75 | 14.72 | -29.15 | 6.53 | -7.37 | 2.32 | 2.55 | - | ||
2023/7 | 0.65 | -28.83 | -26.84 | 5.72 | -4.5 | 2.45 | 2.42 | - | ||
2023/6 | 0.92 | 4.35 | -0.75 | 5.06 | -0.63 | 2.52 | 2.21 | - | ||
2023/5 | 0.88 | 21.39 | 3.79 | 4.15 | -0.69 | 2.44 | 2.29 | - | ||
2023/4 | 0.72 | -13.53 | -19.97 | 3.27 | -1.68 | 2.41 | 2.31 | - | ||
2023/3 | 0.84 | -2.24 | -17.9 | 2.55 | 4.98 | 2.55 | 2.15 | - | ||
2023/2 | 0.86 | 0.19 | 22.15 | 1.71 | 21.24 | 2.72 | 2.02 | - | ||
2023/1 | 0.85 | -15.28 | 20.26 | 0.85 | 20.26 | 2.82 | 1.95 | - | ||
2022/12 | 1.01 | 5.51 | 23.97 | 10.89 | -7.92 | 2.89 | 1.92 | - | ||
2022/11 | 0.96 | 2.73 | 13.81 | 9.89 | -10.24 | 2.82 | 1.97 | - | ||
2022/10 | 0.93 | -0.28 | -10.48 | 8.92 | -12.31 | 2.92 | 1.9 | - | ||
2022/9 | 0.93 | -11.67 | -32.28 | 7.98 | -12.75 | 2.88 | 1.98 | - | ||
2022/8 | 1.06 | 18.46 | 11.15 | 7.05 | -9.46 | 2.87 | 1.98 | - | ||
2022/7 | 0.89 | -3.45 | 11.33 | 5.99 | -12.35 | 2.66 | 2.14 | - | ||
2022/6 | 0.92 | 9.14 | -0.31 | 5.1 | -15.47 | 2.67 | 2.13 | - | ||
2022/5 | 0.85 | -6.4 | -14.05 | 4.18 | -18.22 | 2.77 | 2.06 | - | ||
2022/4 | 0.9 | -11.3 | -22.98 | 3.33 | -19.38 | 2.62 | 2.17 | - | ||
2022/3 | 1.02 | 45.45 | -13.28 | 2.43 | -17.87 | 2.43 | 2.21 | - | ||
2022/2 | 0.7 | -1.34 | -9.63 | 1.41 | -20.64 | 2.22 | 2.41 | - | ||
2022/1 | 0.71 | -12.66 | -29.07 | 0.71 | -29.07 | 2.36 | 2.27 | - | ||
2021/12 | 0.81 | -3.13 | -20.23 | 11.82 | 30.15 | 2.69 | 1.74 | - | ||
2021/11 | 0.84 | -19.2 | -12.11 | 11.01 | 36.78 | 3.25 | 1.44 | - | ||
2021/10 | 1.04 | -24.56 | 3.86 | 10.18 | 43.44 | 3.37 | 1.39 | - | ||
2021/9 | 1.38 | 44.98 | 149.33 | 9.16 | 49.89 | 3.13 | 1.3 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁,包括電信大廠合作案已出貨 | ||
2021/8 | 0.95 | 18.65 | 77.82 | 7.78 | 40.58 | 2.68 | 1.52 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
2021/7 | 0.8 | -13.56 | 14.75 | 6.83 | 36.52 | 2.71 | 1.5 | - | ||
2021/6 | 0.93 | -5.89 | 4.74 | 6.03 | 39.26 | 3.08 | 1.17 | - | ||
2021/5 | 0.98 | -16.12 | 58.29 | 5.11 | 49.21 | 3.33 | 1.09 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
2021/4 | 1.17 | -0.14 | 85.86 | 4.13 | 47.3 | 3.12 | 1.16 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
2021/3 | 1.17 | 51.58 | 70.46 | 2.95 | 36.05 | 2.95 | 1.25 | 因美國疫情影響降低,醫療器材及遙控模型市場需求強勁 | ||
2021/2 | 0.78 | -22.57 | 6.19 | 1.78 | 19.98 | 2.8 | 1.32 | - | ||
2021/1 | 1.0 | -1.77 | 33.41 | 1.0 | 33.41 | 2.98 | 1.24 | - | ||
2020/12 | 1.02 | 6.72 | 69.24 | 9.07 | 11.27 | 2.97 | 1.22 | 美國醫療器材通路客戶受疫情影響降低,營業額回升,美國遙控模型子公司感恩節與耶誕節旺季拉貨及通路商強勁需求所致 | ||
2020/11 | 0.95 | -4.51 | 54.2 | 8.05 | 6.32 | 2.51 | 1.44 | 美國醫療器材通路客戶受疫情影響降低,營業額回升,美國遙控模型子公司感恩節與耶誕節旺季拉貨及通路商強勁需求所致 | ||
2020/10 | 1.0 | 81.09 | 32.32 | 7.09 | 2.01 | 2.09 | 1.74 | - | ||
2020/9 | 0.55 | 3.4 | -23.48 | 6.09 | -1.81 | 1.78 | 2.12 | - | ||
2020/8 | 0.53 | -23.42 | 20.62 | 5.54 | 1.07 | 2.12 | 1.79 | - | ||
2020/7 | 0.7 | -21.09 | -3.73 | 5.0 | -0.52 | 2.2 | 1.72 | - | ||
2020/6 | 0.88 | 42.21 | 4.26 | 4.31 | 1.05 | 2.14 | 1.46 | - | ||
2020/5 | 0.62 | -1.52 | -17.31 | 3.42 | -1.06 | 1.94 | 1.61 | - | ||
2020/4 | 0.63 | -8.42 | 0.66 | 2.8 | 3.4 | 2.05 | 1.53 | - | ||
2020/3 | 0.69 | -5.55 | -13.88 | 2.17 | 4.21 | 2.17 | 1.42 | - | ||
2020/2 | 0.73 | -2.73 | 27.25 | 1.48 | 15.49 | 2.08 | 1.48 | - | ||
2020/1 | 0.75 | 24.59 | 5.93 | 0.75 | 5.93 | 0.0 | N/A | - | ||
2019/12 | 0.6 | -2.75 | 7.05 | 8.17 | -6.26 | 0.0 | N/A | - |